OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao
Cells (2023) Vol. 12, Iss. 17, pp. 2147-2147
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 39

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 10

Boosting CAR-T cell therapy through vaccine synergy
Yan-Ruide Li, Zibai Lyu, Xinyuan Shen, et al.
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 2

Recent advances in exosome-based immunotherapy applied to cancer
Jindong Xie, Zihan Zheng, Ling Tuo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28

Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 6

Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13

Dendritic cells: the yin and yang in disease progression
Carlos Jiménez‐Cortegana, Francisca Palomares, Gonzalo Álba, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5

CircRNA-loaded DC vaccine in combination with low-dose gemcitabine induced potent anti-tumor immunity in pancreatic cancer model
Zongyu Cai, Qimuge Wuri, Yang Song, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access

Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer
Julia S. Hillmann, Nicolaì Maass, Dirk Bauerschlag, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access

Therapeutic role of immune cells against colon cancer
Manoj Kumar Gupta, Gayatri Gouda, Ramakrishna Vadde
Elsevier eBooks (2025), pp. 127-146
Closed Access

Therapeutic Vaccines for Hematological Cancers: A Scoping Review of This Immunotherapeutic Approach as Alternative to the Treatment of These Malignancies
Fernando Augusto Siqueira Mathias, Maria Gabriela Reis Carvalho, Jerônimo Conceição Ruiz
Vaccines (2025) Vol. 13, Iss. 2, pp. 114-114
Open Access

Revolutionizing cancer treatment: The power of dendritic cell-based vaccines in immunotherapy
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Reza Heidari, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117858-117858
Closed Access

Nanomaterials in gastric cancer: pioneering precision medicine for diagnosis, therapy, and prevention
Tiantian Liu, Ying-Qiu Gu, Zaili Yang, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access

A 5-Year Update on the Clinical Development of Cancer Cell-Based Vaccines for Glioblastoma Multiforme
Almohanad A. Alkayyal, Ahmad Bakur Mahmoud
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 376-376
Open Access

Identification of new immune target and signaling for cancer immunotherapy
S. P. Narote, Sharav Desai, Vipul P. Patel, et al.
Cancer Genetics (2025)
Closed Access

A new era of cancer immunotherapy: vaccines and miRNAs
Gitika Sareen, Maneesh Mohan, Ashi Mannan, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access

Stem Cells in Cancer: From Mechanisms to Therapeutic Strategies
Laurence Haddadin, Xueqin Sun
Cells (2025) Vol. 14, Iss. 7, pp. 538-538
Open Access

Adenovirus-based strategies for cancer vaccines
Kexin Geng, William E. Gillanders
Elsevier eBooks (2025), pp. 545-572
Closed Access

Injectable Hydrogels: A Paradigm Tailored with Design, Characterization, and Multifaceted Approaches
Rishika Singhal, Manoj Kumar Sarangi, Goutam Rath
Macromolecular Bioscience (2024) Vol. 24, Iss. 7
Closed Access | Times Cited: 4

Dendritic Cell-Based Glioblastoma Vaccines: Advances and Challenges
Zuowen Zhang, Mingchang Li, Jie Huang
IntechOpen eBooks (2025)
Closed Access

Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment
Xiaoyu Huang, Xiaolong Zhu, Huan Yang, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1462-1462
Open Access | Times Cited: 3

Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy
Azadeh Eskandari, Thean Chor Leow, Mohd Basyaruddin Abdul Rahman, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3

Tug of War: Understanding the Dynamic Interplay of Tumor Biomechanical Environment on Dendritic Cell Function
Brian Chesney Quartey, Gabriella Torres, Mei ElGindi, et al.
Mechanobiology in Medicine (2024) Vol. 2, Iss. 3, pp. 100068-100068
Open Access | Times Cited: 3

The current socioeconomic and regulatory landscape of immune effector cell therapies
Chiranjeevi Sainatham, Devvrat Yadav, Aravind Dilli Babu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top